The advisory group provides advice on:
- the scientific validity of research into the safety and effectiveness of potential COVID-19 vaccines, tests and treatments
- purchasing COVID-19 vaccines, tests and treatments for Australia
- the options available for manufacturing and packaging COVID-19 vaccines and treatments in Australia
- distribution and logistics associated with potential COVID-19 vaccines
- other technical matters related to COVID-19 vaccines and treatments.
Find out more:
Members
|
Member |
Background and experience |
|---|---|
|
Prof Brendan Murphy AC (Chair) |
Secretary, Department of Health and Aged Care |
|
Prof Paul Kelly (Deputy Chair) |
Chief Medical Officer, Department of Health and Aged Care |
| Prof Nigel Crawford | Chair, Australian Technical Advisory Group on Immunisation |
|
Dr John Anderson |
Independent Advisor |
|
Prof Chris Blyth |
Paediatric Infectious Diseases Physician and Clinical Microbiologist |
|
Prof Allen Cheng |
Infectious Disease Physician and Professor of Infectious Diseases Epidemiology |
|
Dr Cathy Foley AO PSM |
Australia’s Chief Scientist |
|
Mr Rob Hetherington |
Independent Adviser |
|
Dr Larry Marshall |
Chief Executive, CSIRO |
|
Ms Sue MacLeman |
Chair, MTP Connect |
|
Ms Kirsten O’Doherty |
Independent Adviser |
|
Dr Felicia Pradera |
Program Manager for Medical Countermeasures Development, DMTC |
|
Mr Mark Sullivan |
Managing Director, Medicines Development Ltd |
|
Prof Andrew Wilson |
Chair, Pharmaceutical Benefits Advisory Committee |
| Prof Kanta Subbarao | WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory Professor |
Meetings
The advisory group meets on an as-needs basis, determined by the Secretary of the Department of Health and Aged Care.